Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.8K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.8K
Accessory Glands of the Male Reproductive System01:16

Accessory Glands of the Male Reproductive System

2.8K
The accessory ducts involved in sperm maturation and transportation include the epididymides, vasa deferentia, ejaculatory ducts, and urethra. These ducts play a critical role in the maturation, storage, and transportation of sperm from the testes to the urethra, where it is then released during ejaculation.
The epididymis is a small, comma-shaped organ located at the back of each testicle. The epididymis can be divided into three main parts: the head, body, and tail. The head of the epididymis...
2.8K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

466
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
466
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

341
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
341
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity.

British journal of cancer·2026
Same author

FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors.

Cancer medicine·2025
Same author

ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.

The Journal of pathology·2023
Same author

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.

Oncogene·2023
Same author

The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.

Molecular cancer·2022
Same author

ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate.

FEBS open bio·2022
Same journal

Ablative radiotherapy in castration-resistant prostate cancer.

BJU international·2026
Same journal

Longitudinal circulating tumour DNA identifies patients at high risk of upstaging and recurrence in non-muscle-invasive bladder cancer.

BJU international·2026
Same journal

Venous thromboembolism after penile cancer surgery: a UK PeCaN study.

BJU international·2026
Same journal

Comment on 'Tumour size outperforms nephrometry scores to predict surgical success following partial nephrectomy'.

BJU international·2026
Same journal

STHLM3 NorDCaP: prospective multicentre trial of Stockholm3 for active surveillance biopsy guidance.

BJU international·2026
Same journal

F-URS with FANS versus mPCNL for 2-3 cm UUTS: a RCT with a subgroup analysis of 2-2.5 cm stones.

BJU international·2026
See all related articles

Related Experiment Video

Updated: Dec 9, 2025

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.4K

Benign prostatic hyperplasia - what do we know?

Conor M Devlin1,2, Matthew S Simms2, Norman J Maitland1

  • 1Cancer Research Unit, Department of Biology, University of York, York, UK.

BJU International
|September 7, 2020
PubMed
Summary
This summary is machine-generated.

Benign prostatic hyperplasia (BPH) pathogenesis involves multiple pathways including inflammation and stem cells. Understanding these mechanisms is crucial for improving current medical therapies for this common condition.

Keywords:
#UroBPHbenign prostatic hyperplasiagrowth factorshormonesinflammationtelomerasetreatment

More Related Videos

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.7K
Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.5K

Related Experiment Videos

Last Updated: Dec 9, 2025

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.4K
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

19.7K
Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.5K

Area of Science:

  • Urology
  • Pathophysiology
  • Endocrinology

Background:

  • Benign prostatic hyperplasia (BPH) is a widespread condition with substantial global health and economic consequences.
  • The precise initiation and progression mechanisms of BPH remain incompletely understood.
  • Existing medical therapies for BPH face challenges due to incomplete understanding of its pathogenesis.

Purpose of the Study:

  • To review and synthesize historical and current hypotheses regarding the pathogenesis of benign prostatic hyperplasia (BPH).
  • To explore the implications of these hypotheses for the development and efficacy of current medical therapies for BPH.
  • To highlight the role of prostate cell subpopulations and their impact on treatment response.

Main Methods:

  • Comprehensive literature review of studies on benign prostatic hyperplasia (BPH).
  • Analysis of proposed pathways involved in BPH development, including hormonal, inflammatory, and cellular mechanisms.
  • Examination of the relationship between BPH pathogenesis and treatment outcomes.

Main Results:

  • Multiple hypotheses for BPH pathogenesis exist, involving androgens, estrogens, insulin, inflammation, stem cells, and telomerase.
  • Pathways initially proposed decades ago are regaining favor, with a current focus on inflammation-driven processes.
  • Prostate cell subpopulations and their physiology may explain variable responses to medical therapies.

Conclusions:

  • The incomplete understanding of BPH pathogenesis affects the effectiveness of medical treatments.
  • Further research into BPH mechanisms is essential for identifying novel therapeutic strategies.
  • Addressing the complex pathophysiology of BPH can lead to improved patient outcomes.